Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells
/in Breast Cancer, Dendritic Cells, International Publications /von 2006-12-23 / Breast Cancer Res. Treat. 2007 Nov;105(3):277-86[Clinical impact of locoregional hyperthermia in gynecological oncology]
/in Breast Cancer, Cervical Cancer, Hyperthermia, International Publications /von 2006-10-01 / Zentralbl Gynakol 2006 Oct;128(5):255-60Antitumor immune response induced by i.t. injection of vector-activated dendritic cells and chemotherapy suppresses metastatic breast cancer
/in Breast Cancer, International Publications /von 2006-08-01 / Mol. Cancer Ther. 2006 Aug;5(8):1975-85Dendritic cell immunotherapy for breast cancer
/in Breast Cancer, International Publications /von 2006-06-01 / Expert Opin Biol Ther 2006 Jun;6(6):591-604HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination
/in Breast Cancer, Dendritic Cells, International Publications /von 2006-05-25 / Gene Ther. 2006 Oct;13(19):1391-402Targeting tumours by adoptive transfer of immune cells
/in Breast Cancer, International Publications /von 2006-05-01 / Clin. Exp. Pharmacol. Physiol. 2006 May-Jun;33(5-6):569-74Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer
/in Breast Cancer, International Publications /von 2006-05-01 / Int. J. Cancer 2006 May;118(9):2220-31Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses
/in Breast Cancer, International Publications /von 2006-04-01 / Clin. Exp. Immunol. 2006 Apr;144(1):41-7Randomized trial of hyperthermia and radiation for superficial tumors
/in Breast Cancer, Hyperthermia, International Publications, Malignant Melanoma /von 2005-05-01 / J. Clin. Oncol. 2005 May;23(13):3079-85
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de